HOME >> BIOLOGY >> NEWS
Why results from genetic tests should be available to medical insurance companies

Authors of a Viewpoint article in this week's issue of THE LANCET discuss the ethical considerations surrounding genetic test results and disclosure to medical insurance companies-the authors outline their reasons for supporting the disclosure of such test results to make health insurance more equitable.

Nick Raithatha and Richard D. Smith from the University of East anglia, UK, discuss the public concern that genetic testing will be misused by insurers, discriminating between those identified as low risk and high risk. The ethical arguments related to this concern rely on the nature and predictive power of the test, the requirement for the test, and disclosure of the test result. The authors discuss these issues, using the example of two individuals at increased risk of coronary heart disease. Individual A has a higher risk of the disease compared with the age and sex adjusted average, identified by a blood cholesterol test, and individual B has the same increase in risk, but it was identified by a hypothetical genetic test. At present, individual A has to declare this information to the insurance company, whereas individual B does not.

The authors comment: 'Our contention is that this situation is unjustifiable, that genetic testing poses no new ethical issues compared with already accepted (non-genetic) practices adopted by insurance companies, but rather that the present inconsistency concerning disclosure of results of genetic and non-genetic based tests seems unethical. The shortage of information on the links between genetic status, lifestyle, and future health might make use of genetic tests inappropriate, rather than unethical, for premium assessment. However, with the rapid progress made in the area of genetics, these links may soon be clearly established, and our contention is based on this development.'

Dr. Raithatha concludes: "Perhaps the biggest obstacle remains public perception of genetic testing. The primary task facing the me
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
29-Jan-2004


Page: 1 2

Related biology news :

1. Warren Pharmaceuticals publishes results of preclinical evaluation
2. U of T microbiologists achieve results with pattern recognition software
3. Loss of circadian genes results in epilepsy
4. VIB presents its annual results at BIO2004 in San Francisco
5. Scientists discover why not enough choline results in fewer brain cells, poorer memory
6. Heart and lung transplantation clinical trial results to be announced at ISHLT meeting
7. Sequencing project results in six-fold reduction of effective size of maize genome
8. VaxGen reports Phase I clinical trial results of anthrax vaccine candidate
9. Duke open-air experiment results could deflate hopes that forests can alleviate global warming
10. Studies suggest brain injury results from developmental exposure to alcohol, anesthesia, and lead
11. Applying results of womens health initiative study to individual patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/2/2018)... ... August 02, 2018 , ... RxS ... and biotech companies, today announced that Mark Jara, principal of the organization, has ... the life sciences industry. Individuals named to PharmaVOICE 100 are leaders who drive ...
(Date:8/1/2018)... ... August 01, 2018 , ... ... PA’s, RN’s, LPN’s, MA's and Administrative staff. , This full day course is ... biologics. The course will expose your staff to regenerative medicine procedures and processing ...
(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... ... welcomes William “Will” Muzek as Business Development Manager. In this role, Mr. Muzek ... and to accelerate Lifecycle’s continued growth and expansion. , With over 20 ...
Breaking Biology News(10 mins):
(Date:7/31/2018)... ... 2018 , ... Leading regenerative veterinary medicine company, VetStem Biopharma, ... adipose tissue-derived stem cells to treat or prevent inflammation at the site of ... specifically, VetStem has been issued similar patents that cover the United States as ...
(Date:7/26/2018)... ... July 26, 2018 , ... Ariadne ... of a biofield energy treated nutraceutical to improve anti-inflammatory and immune function responses. ... assessed in the preclinical research, were significantly reduced. Results are as follows:, ...
(Date:7/25/2018)... ... July 25, 2018 , ... ... Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including ... podiatric medical education and clinical experience. Their students receive comprehensive academic training ...
(Date:7/24/2018)... ... 2018 , ... R3 Stem Cell is now offering regenerative therapies for COPD ... Double Board Certified providers, with outcomes significantly improving patient quality of life. , Traditional ... nothing to help repair and regenerate damaged lung tissues. Stem cell therapy for ...
Breaking Biology Technology:
Cached News: